摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-carboethoxy-4-hydroxy-5,6,7,8-tetrahydro-2(1H)-quinolone | 56517-53-4

中文名称
——
中文别名
——
英文名称
3-carboethoxy-4-hydroxy-5,6,7,8-tetrahydro-2(1H)-quinolone
英文别名
4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydro-3(1H)-quinolinecarboxylic acid ethl ester;4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxylic acid ethyl ester;ethyl 4-hydroxy-2-oxo-1,2,5,6,7,8-hexahydroquinoline-3-carboxylate;3-carboethoxy-4-hydroxy-5,6,7,8-tetrahydrocarbostyril;ethyl 4-hydroxy-2-oxo-5,6,7,8-tetrahydro-1H-quinoline-3-carboxylate
3-carboethoxy-4-hydroxy-5,6,7,8-tetrahydro-2(1H)-quinolone化学式
CAS
56517-53-4
化学式
C12H15NO4
mdl
——
分子量
237.255
InChiKey
LOGDXXVRFXBURG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF
    申请人:FUJII Nobuhiro
    公开号:US20090227561A1
    公开(公告)日:2009-09-10
    The present invention provides a compound having a superior Smo inhibitory activity and lower toxicity, which is sufficiently satisfactory as a pharmaceutical product. The present invention provides a compound represented by the formula wherein ring A is 5- to 7-membered ring optionally having substituent(s), where substituents are optionally bonded to each other to form a ring; X is O, S or NR 1 (R 1 is a hydrogen atom or a hydrocarbon group optionally having substituent(s)); R 2 is carbamoyl optionally having substituent(s); and R 3 is hydroxy optionally having substituent(s), or a salt thereof.
    本发明提供了一种具有优异的Smo抑制活性和较低毒性的化合物,该化合物作为药物产品是完全令人满意的。本发明提供了一种由下式表示的化合物: 其中,环A是5-至7-成员环,可选择地具有取代基,其中取代基可选择地与彼此结合形成环;X是O、S或NR1(R1是氢原子或具有取代基的碳氢基团);R2是氨基甲酰,可选择地具有取代基;R3是羟基,可选择地具有取代基,或其盐。
  • Tetrahydrocarbostyril derivatives for the prophylaxis of asthma,
    申请人:Beecham Group Limited
    公开号:US04006237A1
    公开(公告)日:1977-02-01
    Pharmaceutical compositions having anti-allergy activity in which the active anti-allergy agents are certain 3-nitro-.alpha.-pyridones and their pharmaceutically acceptable salts formulated in one or more pharmaceutically acceptable carriers.
    具有抗过敏活性的药物组合物,其中活性抗过敏剂是某些3-硝基-.alpha.-吡啶酮及其药学上可接受的盐,在一个或多个药学上可接受的载体中制剂。
  • 4-Hydroxy-3-nitro-5,6,7,8 tetrahydro-carbostyrils
    申请人:Beecham Group Limited
    公开号:US04031099A1
    公开(公告)日:1977-06-21
    A class of 4-hydroxy-3-nitro-.alpha.-pyridones have anti-allergic activity.
    一类4-羟基-3-硝基-α-吡啶酮具有抗过敏活性。
  • Bicyclic fused pyridinyl amides and advantagesous compositons thereof for use as fungicides
    申请人:Bisaha Joseph John
    公开号:US20050020644A1
    公开(公告)日:2005-01-27
    Compounds of Formula I, including all geometric and stereoisomers, N-oxides, and agriculturally suitable salts thereof: (Formula I); wherein X and either Y or Z are a linking chain 3 or 4 atoms in length attached to contiguous carbon atoms and are taken together with said carbon atoms to form a fused phenyl ring, a fused 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring optionally including one or two ring members selected from the group consisting of C(═O), SO or S(O) 2 , or a fused 5- or 6-membered heteroaromatic ring, each fused ring optionally substituted with one to three substituents independently selected from R 7 ; and R 1 , R 2 , R 5 , R 6 R 7 , m and p are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula I and a method for controlling plant diseases caused by fungal plant pathogens that involves applying an effective amount of a compound of Formula I.
    公式I的化合物,包括所有的几何和立体异构体,N-氧化物和适用于农业的盐:(公式I);其中X和Y或Z之一是一个链接链,长度为3或4个原子,连接到相邻的碳原子,并与该碳原子一起形成一个融合的苯环,一个融合的5-或6-成员非芳香碳环或杂环,可选地包括来自C(═O),SO或S(O)2的一个或两个环成员,或一个融合的5-或6-成员杂芳环,每个融合环可选地被一个到三个独立选择的R7取代; R1,R2,R5,R6R7,m和p如披露中所定义。还披露了包含公式I化合物的组合物以及一种用公式I化合物的有效量来控制由真菌植物病原体引起的植物病害的方法。
  • Fused heterocyclic derivative and use thereof
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US08217176B2
    公开(公告)日:2012-07-10
    The present invention provides a compound having a superior Smo inhibitory activity and lower toxicity, which is sufficiently satisfactory as a pharmaceutical product. The present invention provides a compound represented by the formula wherein ring A is 5- to 7-membered ring optionally having substituent(s), where substituents are optionally bonded to each other to form a ring; X is O, S or NR1 (R1 is a hydrogen atom or a hydrocarbon group optionally having substituent(s)); R2 is carbamoyl optionally having substituent(s); and R3 is hydroxy optionally having substituent(s), or a salt thereof.
    本发明提供了一种化合物,具有优越的Smo抑制活性和较低的毒性,足以作为药物产品。本发明提供的化合物由以下式子表示:其中环A是5-至7-成员环,可选地具有取代基,其中取代基可选择结合在一起形成环;X是O、S或NR1(R1是氢原子或具有取代基的碳氢基团);R2是氨基甲酰基,可选地具有取代基;R3是羟基,可选地具有取代基,或其盐。
查看更多